Dr. Rosie Scuccimarri, McGill University, Montréal, QC

With the worldwide COVID-19 pandemic, a “new” multisystem inflammatory syndrome was recognized in children. The Pediatric Inflammatory Multisystem Syndrome (PIMS) resembles Kawasaki disease. Is it the same disease? What are the differences described between these diseases? How can we identify these children? How should we manage these patients? These are a few of the questions to be answered at this presentation.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Describe the Pediatric Inflammatory Multisystem Syndrome associated with COVID-19; and
  • Integrate a management approach for caring for children with PIMS.

CanMEDs Competencies addressed:
Collaborator, Medical Expert